Antihypertensive drugs in the stroke-prone spontaneously hypertensive rat

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 925-936

  Richer, C ^a   Vacher, E ^a   Fornes, P ^a   Giudicelli, J F ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antihypertensive Drugs; Cerebral Vessels; Stroke; Stroke Prone Spontaneously Hypertensive Rat

Indexed keywords

AMILORIDE; AMLODIPINE; CAPTOPRIL; CICLETANINE; CILAZAPRIL; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; MIBEFRADIL; NILVADIPINE; QUINAPRIL; RELCOVAPTAN; TRANDOLAPRIL; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BRAIN BLOOD FLOW; BRAIN PROTECTION; CONFERENCE PAPER; DIURETIC THERAPY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

EID: 0030762106     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083196     Document Type: Conference Paper

References (37)

1. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974, 34-35(Suppl.I): 1143-153.
2. Tagami M, Nara Y, Kubota A, Sunaga T, Maezawa H, Fujino H, Yamori Y. Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. Stroke 1987, 18: 733-740.
3. Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol. 1980, 51: 179-184.
4. Baumbach G.L., Dobrin P.B., Hart M.N., Heistad D.D. Mechanics of cerebral arterioles in hypertensive rats. Circ Res. 1988, 62: 56-64.
5. Smeda J.S. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol. 1992, 70: 552-564.
6. Mayhan W.G., Faraci F.M. Cerebral vasconstrictor responses to serotonin during chronic hypertension. Hypertension 1990, 15: 872-876.
7. Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol. 1979, 236: H409-416.
8. + feeding in stroke-prone hypertensive rats. Hypertension 1990, 15: 318-326.
9. Yamori Y, Horie R, Tanase H, Fujiwara K, Nara Y, Lovenberg W. Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. Hypertension 1984, 6: 49-53.
10. Horie R., Yamori Y., Nara Y., Sawamura M., Mizushima S. Aggravating effects of isolated caging n the development of hypertension and its complications in stroke-prone spontaneously hypertensive rats (SHR-SP) and Wistar-Kyoto rats (WKY). Clin Exp Hypertens. 1991, A13: 859-864.
11. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977, 41: 19-26.
12. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli J.F. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol. 1993, 22: 305-313.
13. Vacher E, Fornes P, Domergue V, Richer C, Bruneval P, Giudicelli J.F. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1993, 6: 951-959.
14. Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli J.F. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist after treatment withdrawal. Am J Cardiol. 1994, 73: 26C-35C.
15. Vacher, E., Richer, C., Fornes, P., Clozel, J.P., Giudicelli, J.F. Mibefradil, a selective calcium T-channel blocker, in the stroke-sprone spontaneously hypertensive rat. J Cardiovasc Pharmacol. 1996, 27: 686-694.
16. Vacher, E., Richer, C., Giudicelli, J.F. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats. J Hypertens. 1996, in press.
17. Stier C.T., Chander P.N., Gutstein W.H., Levine S, Itskovitz H.D. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens. 1991, 4: 680-687.
18. Stier C.T., Benter I.F., Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskovitz H.D. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 1989, 13: 115-121.
19. Hajdu, M.A., Heistad, D.D., Baumbach, G.L. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991, 17: 308-316.
20. Camargo M.J.F., Von Lutterotti N, Pecker M.S., James G.D., Timmermans P.B.M.W.M., Laragh J.H. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens. 1991, 4: S341-345.
21. Gries J, Kretzschmar R, Neumann B.W. Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J Cardiovasc Pharmacol. 1989, 13(Suppl.4): S79-82.
22. Nayler, W.G. Vascular injury : mechanisms and manifestations. Am J Med. 1991, 90(Suppl.4B): 8S-13S.
23. Takakura S, Furuichi Y, Yamamoto T, Ogawa T, Satoh H, Mori J. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Stroke 1994, 25: 677-683.
24. Smeda, J.S., Tkachenko, O. Effects of diuretics on stroke development in Kyoto-Wistar stroke-prone spontaneously hypertensive rats. Clin Sci. 1991, 81: 335-340.
25. Ruchoux, M.M., Bakri, F., Bosquet, D., Droy, M.T., Guillemain, J., Lhuintre, Y. Comparaison des effets du ciclétanine et du captopril sur les lésions rénales et cardiaques du rat spontanément hypertendu (SHR-SP). Arch Mal Coeur 1989, 82: 169-174.
26. Miyagishi, A., Maniwa, T., Noguchi, T., Hara, Y. Prevention of cerebral stroke by arotinolol in salt-loaded SHR-SP. Clin Exp Hypertens. 1991, A13: 1077-1089.
27. Vacher, E., Richer, C., Cazaubon, C., Fornes, P., Nisato, D., Giudicelli, J. F. Are vasopressin peripheral V1 receptors involved in the development of malignant hypertension and stroke in SHR-SPs. Fundam Clin Pharmacol. 1995, 9: 469-478.
28. Stier, C.T., Adler, L.A., Levine, S., Chander, P.N. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens. 1993, 11(Suppl.3): S37-S42.
29. 2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. Stroke 1988, 19: 1145-1150.
30. Yamori, Y., Horie, R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke, 1977, 8: 456-461.
31. Kazda, S., Grunt, M., Hirth, C., Preis, W., Stasch, J.P. Calcium antagonism and protection of tissues from calcium damage. J Hypertens. 1987, 5(Suppl.4): S37-S42.
32. Lens, L., Luckhaus, G., Stasch, J.P., Kazda, S. Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine. Stroke 1990, 21 (Suppl.IV): IV111-IV112.
33. Shinyama H, Nagai H, Kawamura T, Narita Y, Uchida T, Watanabe M, Kagitani Y. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats. J Pharmacol Exp Ther. 1995, 272: 911-919.
34. Contard F, Sabri A, Glukhova M, Sartore S, Marotte F, Pomies J.P., Schiavi P, Guez D, Samuel J.L., Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 1993, 22: 665-676.
35. Robertson A.L., Khairallah, P.A. Arterial endothelial permeability and vascular disease : the "trap door" effect. Exp Mol Pathol. 1973, 18: 241-260.
36. Hajdu M.A., Baumbach G.L. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol. 1994, 266: H1027-H1033.
37. Stier C.T., Sim J., Mahboubi K., Shen W., Levine S., Chander P.N. Prevention of stroke and hypertensive renal disease by the angiotensin II receptor antagonist DUP 753 in salt-loaded stroke-prone SHR. In: McGregor G.A., Sever P., eds, Current advances in ACE inhibition, London : Churchill Livingstone Publ., 1991 : 252-255.